We explore real-life reformation here in this informed, online community.
If confirmed by the Senate, Robert Kennedy will take charge of HHS, which controls the FDA, CDC, and NIH. If not confirmed by the Senate, he can still be appointed by the President under the Recess Appointments Clause in Article II, Section 2, Clause 3 of the Constitution.
The following crises were published in the Journal of the American Medical Association, on July 26, 2000. The government has yet to take steps to address them.
The author was Dr. Barbara Starfield, a widely respected public health expert at the Johns Hopkins School of Public Health. Her review, “Is US Health Really the Best in the World?” revealed that, every year in the US, the medical system kills 225,000 people, and severely maims many more.
The breakdown 24 years ago has only become worse. At that time, the FDA approved drugs which killed 106,000 people, and mistreatment and errors in hospitals killed 119,000 people. Priorities for reform:
ONE: The FDA has been routinely approving medicines as safe, when they actually kill people.
TWO: Prestigious medical journals routinely publish glowing studies of medical drugs that are actually killing people.
THREE: The federal government has done NOTHING substantial to reform the deadly medical system.
FOUR: The mainstream press failed to follow up or investigate this explosive ongoing tragedy.
FIVE: The US Centers for Disease Control and Prevention (CDC) has never highlighted THIS MEDICAL cause of disease.
SIX: The FDA has never made moves to completely overhaul its drug-approval process.
The FDA has rejected its strongest safety warning for Covid mRNA vaccines despite acknowledging that children were killed by the products.
This news surfaced during a televised Bloomberg interview with FDA Commissioner Marty Makary, who said the agency has “no plans” to apply its strongest safety warning to Covid mRNA vaccines.
In that interview, Makary confirmed that the FDA’s own safety and epidemiology centre had formally recommended a boxed warning — a step reserved, under FDA rules, for drugs with “special problems, particularly ones that may lead to death or serious injury.”
